Recent advances in the treatment of systemic sclerosis associated interstitial lung disease

被引:4
作者
Kamenova, Antoniya [1 ]
Tzouvelekis, Argyris [2 ]
Margaritopoulos, George A. [1 ]
机构
[1] London North West Univ Hosp HT, Interstitial Lung Dis Unit, London, England
[2] Univ Patras, Resp Med Dept, Patras, Greece
关键词
interstitial lung disease; systemic sclerosis; cyclophosphamide; rituximab; mycophenolate mofetil; tocilizumab; nintedanib; pirfenidone; IDIOPATHIC PULMONARY-FIBROSIS; CIGARETTE-SMOKING; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; TELOMERE LENGTH; PHASE-II; SCLERODERMA; SURVIVAL; CYCLOPHOSPHAMIDE; THERAPY;
D O I
10.3389/fmed.2023.1155771
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Connective tissue diseases (CTDs) are a heterogenous group of systemic inflammatory disorders. The development of connective tissue disease-associated interstitial lung disease (CTD-ILD) is a key complication associated with significant morbidity and mortality. The aim of this review is to explore the pathogenesis of CTD-ILD and summarize the recent evidence from clinical trials for novel treatment options, including the role of antifibrotics and immunomodulatory therapies with a focus on systemic sclerosis associated ILD. Further clinical trials are ongoing to explore combination therapies and more targeted therapeutic options. Clinicians remain faced with the difficult challenge of appropriately selecting patients who will benefit from the available therapies and timing the start of therapy at the most suitable part of the disease course.
引用
收藏
页数:9
相关论文
共 82 条
[71]   Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation [J].
Stuart, Bridget D. ;
Lee, Joyce S. ;
Kozlitina, Julia ;
Noth, Imre ;
Devine, Megan S. ;
Glazer, Craig S. ;
Torres, Fernando ;
Kaza, Vaidehi ;
Girod, Carlos E. ;
Jones, Kirk D. ;
Elicker, Brett M. ;
Ma, Shwu-Fan ;
Vij, Rekha ;
Collard, Harold R. ;
Wolters, Paul J. ;
Garcia, Christine Kim .
LANCET RESPIRATORY MEDICINE, 2014, 2 (07) :557-565
[72]   Cyclophosphamide versus placebo in scleroderma lung disease [J].
Tashkin, Donald P. ;
Elashoff, Robert ;
Clements, Philip J. ;
Goldin, Jonathan ;
Roth, Michael D. ;
Furst, Daniel E. ;
Arriola, Edgar ;
Silver, Richard ;
Strange, Charlie ;
Bolster, Marcy ;
Seibold, James R. ;
Riley, David J. ;
Hsu, Vivien M. ;
Varga, John ;
Schraufnagel, Dean E. ;
Theodore, Arthur ;
Simms, Robert ;
Wise, Robert ;
Wigley, Fredrick ;
White, Barbara ;
Steen, Virginia ;
Read, Charles ;
Mayes, Maureen ;
Parsley, Ed ;
Mubarak, Kamal ;
Connolly, M. Kari ;
Golden, Jeffrey ;
Olman, Mitchell ;
Fessler, Barri ;
Rothfield, Naomi ;
Metersky, Mark .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (25) :2655-2666
[73]   Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease [J].
Tashkin, Donald P. ;
Elashoff, Robert ;
Clements, Philip J. ;
Roth, Michael D. ;
Furst, Daniel E. ;
Silver, Richard M. ;
Goldin, Jonathan ;
Arriola, Edgar ;
Strange, Charlie ;
Bolster, Marcy B. ;
Seibold, James R. ;
Riley, David I. ;
Hsu, Vivien M. ;
Varga, John ;
Schraufnagel, Dean ;
Theodore, Arthur ;
Simms, Robert ;
Wise, Robert ;
Wigley, Fred ;
White, Barbara ;
Steen, Virginia ;
Read, Charles ;
Mayes, Maureen ;
Parsley, Ed ;
Mubarak, Kamal ;
Connolly, M. Kari ;
Golden, Jeffrey ;
Olman, Mitchell ;
Fessler, Barri ;
Rothfield, Naomi ;
Metersky, Mark ;
Khanna, Dinesh ;
Li, Ning ;
Li, Gang .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (10) :1026-1034
[74]   Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial [J].
Tashkin, Donald P. ;
Roth, Michael D. ;
Clements, Philip J. ;
Furst, Daniel E. ;
Khanna, Dinesh ;
Kleerup, Eric C. ;
Goldin, Jonathan ;
Arriola, Edgar ;
Volkmann, Elizabeth R. ;
Kafaja, Suzanne ;
Silver, Richard ;
Steen, Virginia ;
Strange, Charlie ;
Wise, Robert ;
Wigley, Fredrick ;
Mayes, Maureen ;
Riley, David J. ;
Hussain, Sabiha ;
Assassi, Shervin ;
Hsu, Vivien M. ;
Patel, Bela ;
Phillips, Kristine ;
Martinez, Fernando ;
Golden, Jeffrey ;
Connolly, M. Kari ;
Varga, John ;
Dematte, Jane ;
Hinchcliff, Monique E. ;
Fischer, Aryeh ;
Swigris, Jeffrey ;
Meehan, Richard ;
Theodore, Arthur ;
Simms, Robert ;
Volkov, Suncica ;
Schraufnagel, Dean E. ;
Scholand, Mary Beth ;
Frech, Tracy ;
Molitor, Jerry A. ;
Highland, Kristin ;
Read, Charles A. ;
Fritzler, Marvin J. ;
Kim, Grace Hyun J. ;
Tseng, Chi-Hong ;
Elashoff, Robert M. .
LANCET RESPIRATORY MEDICINE, 2016, 4 (09) :708-719
[75]   Human leukocyte antigen class II associations with systemic sclerosis in South Africans [J].
Tikly, M ;
Rands, A ;
McHugh, N ;
Wordsworth, P ;
Welsh, K .
TISSUE ANTIGENS, 2004, 63 (05) :487-490
[76]   The Efficacy and Safety of Pirfenidone Combined With Immunosuppressant Therapy in Connective Tissue Disease-Associated Interstitial Lung Disease: A 24-Week Prospective Controlled Cohort Study [J].
Wang, Jiaqi ;
Wang, Xiao ;
Qi, Xiaoyan ;
Sun, Zhijian ;
Zhang, Tao ;
Cui, Yi ;
Shu, Qiang .
FRONTIERS IN MEDICINE, 2022, 9
[77]   Association of HLA-DPB1 with Scleroderma and Its Clinical Features in Chinese Population [J].
Wang, Jiucun ;
Guo, Xinjian ;
Yi, Lin ;
Guo, Gang ;
Tu, Wenzhen ;
Wu, Wenyu ;
Yang, Li ;
Xiao, Rong ;
Li, Yuan ;
Chu, Haiyan ;
He, Dongyi ;
Jin, Li ;
Mayes, Maureen D. ;
Zou, Hejian ;
Zhou, Xiaodong .
PLOS ONE, 2014, 9 (01)
[78]   New insights into the treatment of CTD-ILD [J].
Wells, Athol U. .
NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (02) :79-80
[79]   Interstitial lung disease in connective tissue disease-mechanisms and management [J].
Wells, Athol U. ;
Denton, Christopher P. .
NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (12) :728-739
[80]   Interstitial Lung Disease in Systemic Sclerosis [J].
Wells, Athol U. ;
Margaritopoulos, George A. ;
Antoniou, Katerina M. ;
Denton, Chris .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (02) :213-221